Commentary:Clinical trials methods and the practice of medicine

Jeffrey L. Probstfield; Michael L. Russell; Abraham Silvers; Dwight L. Goodwin; William Insull

doi:10.1016/S0197-2456(84)80012-4

Commentary:Clinical trials methods and the practice of medicine

Jeffrey L. Probstfield, Michael L. Russell, Abraham Silvers, Dwight L. Goodwin, William Insull

Academic Institute

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

An important potential byproduct from clinical trials is validated clinicalmethods applicable to clinical practice. The potential for improved patient care is separate from the scientific and intellectual answers gained in such trials. The current mechanisms for the transfer of methodological information from clinical trials are inefficient and have identifiable barriers. Methods validated in clinical trials must be recognized and accentuated as a valuable resource. A central repository of clinical trials' methods and a retrieval system dedicated to this unique body of scientific literature is warranted. Reports of methodological advances from clinical trials should be published in the literature read by clinical practitioners. The effective transfer of methods information from clinical trials to the office of the clinical practitioner is possible but requires increased efforts on the part of clinical trials scientists.

Original language	English (US)
Pages (from-to)	321-327
Number of pages	7
Journal	Controlled Clinical Trials
Volume	5
Issue number	4 SUPPL. 1
DOIs	https://doi.org/10.1016/S0197-2456(84)80012-4
State	Published - Dec 1984

ASJC Scopus subject areas

Pharmacology

Access to Document

10.1016/S0197-2456(84)80012-4

Cite this

@article{5febad750854452cbc0930048ddd9ebe,

title = "Commentary:Clinical trials methods and the practice of medicine",

abstract = "An important potential byproduct from clinical trials is validated clinicalmethods applicable to clinical practice. The potential for improved patient care is separate from the scientific and intellectual answers gained in such trials. The current mechanisms for the transfer of methodological information from clinical trials are inefficient and have identifiable barriers. Methods validated in clinical trials must be recognized and accentuated as a valuable resource. A central repository of clinical trials' methods and a retrieval system dedicated to this unique body of scientific literature is warranted. Reports of methodological advances from clinical trials should be published in the literature read by clinical practitioners. The effective transfer of methods information from clinical trials to the office of the clinical practitioner is possible but requires increased efforts on the part of clinical trials scientists.",

author = "Probstfield, {Jeffrey L.} and Russell, {Michael L.} and Abraham Silvers and Goodwin, {Dwight L.} and William Insull",

note = "Funding Information: ACKNOWLEDGMENTS This work was supported in part by Lipid Research Clinic Grant No. 6245-O/02; and Contract No. HL17269-08. We wish to thank Mrs. Gayle Shipp for editorial assistance Copyright: Copyright 2014 Elsevier B.V., All rights reserved.",

year = "1984",

month = dec,

doi = "10.1016/S0197-2456(84)80012-4",

language = "English (US)",

volume = "5",

pages = "321--327",

journal = "Controlled Clinical Trials",

issn = "0197-2456",

publisher = "Elsevier B.V.",

number = "4 SUPPL. 1",

}

TY - JOUR

T1 - Commentary:Clinical trials methods and the practice of medicine

AU - Probstfield, Jeffrey L.

AU - Russell, Michael L.

AU - Silvers, Abraham

AU - Goodwin, Dwight L.

AU - Insull, William

N1 - Funding Information: ACKNOWLEDGMENTS This work was supported in part by Lipid Research Clinic Grant No. 6245-O/02; and Contract No. HL17269-08. We wish to thank Mrs. Gayle Shipp for editorial assistance Copyright: Copyright 2014 Elsevier B.V., All rights reserved.

PY - 1984/12

Y1 - 1984/12

N2 - An important potential byproduct from clinical trials is validated clinicalmethods applicable to clinical practice. The potential for improved patient care is separate from the scientific and intellectual answers gained in such trials. The current mechanisms for the transfer of methodological information from clinical trials are inefficient and have identifiable barriers. Methods validated in clinical trials must be recognized and accentuated as a valuable resource. A central repository of clinical trials' methods and a retrieval system dedicated to this unique body of scientific literature is warranted. Reports of methodological advances from clinical trials should be published in the literature read by clinical practitioners. The effective transfer of methods information from clinical trials to the office of the clinical practitioner is possible but requires increased efforts on the part of clinical trials scientists.

AB - An important potential byproduct from clinical trials is validated clinicalmethods applicable to clinical practice. The potential for improved patient care is separate from the scientific and intellectual answers gained in such trials. The current mechanisms for the transfer of methodological information from clinical trials are inefficient and have identifiable barriers. Methods validated in clinical trials must be recognized and accentuated as a valuable resource. A central repository of clinical trials' methods and a retrieval system dedicated to this unique body of scientific literature is warranted. Reports of methodological advances from clinical trials should be published in the literature read by clinical practitioners. The effective transfer of methods information from clinical trials to the office of the clinical practitioner is possible but requires increased efforts on the part of clinical trials scientists.

UR - http://www.scopus.com/inward/record.url?scp=0021722043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021722043&partnerID=8YFLogxK

U2 - 10.1016/S0197-2456(84)80012-4

DO - 10.1016/S0197-2456(84)80012-4

M3 - Article

AN - SCOPUS:0021722043

SN - 0197-2456

VL - 5

SP - 321

EP - 327

JO - Controlled Clinical Trials

JF - Controlled Clinical Trials

IS - 4 SUPPL. 1

ER -

Commentary:Clinical trials methods and the practice of medicine

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this